Robert Nesse, MD, the senior director of Policy and Payment Reform at Mayo Clinic, discussed the impact of healthcare consolidation for consumers, whether or not they are aware of it, and how the government will respond to this consolidation.
Robert Nesse, MD, the senior director of Policy and Payment Reform at Mayo Clinic, discussed the impact of healthcare consolidation for consumers, whether or not they are aware of it, and how the government will respond to this consolidation.
Transcript (modified)
What are consumer reactions to consolidation in healthcare? Do they know it’s happening? Do they know why it’s happening?
I don’t belive they’re thinking about the megastructures of what’s going on in healthcare, but it can impact them very immediately, and that would be if their provider has changed, their employment status or somebody else’s has changed, the insurance model can change, and then that patient can no longer go to that provider or, at least, not until they change their insurance. Then it’s immediate. And the patient can’t put that into some larger context so that hits immediately.
Another thing I think can happen is as these models change very quickly, benefits models change, too. People that are used to one set of benefits can end up in trouble unless they read carefully the fine print, if you will, of the insurance model going forward—even the bold print of the insurance model going forward—in order to make the transition.
In 2015 there were a number of large healthcare mergers announced. Do you think we’ll start to see the government cracking down on these mergers?
It depends on how they turn out. So remember that while we might have all heard about 50 insurance company mergers, 500 medical groups merged and were acquired last year, in 2015. This is being done not just for market power, there are forces that really the government would like in terms of coordinated care, population health models, more advanced analytics, meaningful use of electronic medical records—all of those require groups to get bigger.
So you really can’t say we want a model in which people require or need integrated care to be successful both in the provider viewpoint and a patient viewpoint, and then say we can’t support the structure that allows that. So I don’t think they’ll be stopped, I think they’ll be heavily regulated and that’s probably appropriate.
Hospital Stays and Probable Dementia as Predictors of Relocation to Long-Term Care Facilities
October 22nd 2024This article explores late-life relocations in patients with dementia, hospital stays, and their implications for health care policy, geriatric care, and future research priorities.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
October 21st 2024Examining care transitions in hospitalized patients revealed lower diagnostic error rates compared with traditional methods, highlighting the effectiveness of this approach in identifying diagnostic challenges.
Read More
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
October 20th 2024The case study, which showed prolonged disease control achieved with gilteritinib in a previously-treated patient with AML with an inv(2)(p23q13) translocation, indicates that gilteritinib can also be used as an anaplastic lymphoma kinase (ALK) inhibitor.
Read More